Literature DB >> 16638846

Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.

Ryan P McCarthy1, Mingsheng Wang, Timothy D Jones, Randall W Strate, Liang Cheng.   

Abstract

PURPOSE: Patients with papillary thyroid carcinoma often have two or more distinct papillary tumors at thyroidectomy. Whether these multifocal papillary lesions are clonally related or whether they arise independently is unknown as previous studies have shown conflicting results. Molecular analysis of microsatellite alterations and X-chromosome inactivation status in separate tumors from the same patient can be used to define the genetic relationships among the multiple coexisting tumors. EXPERIMENTAL
DESIGN: We examined 64 separate tumors from 22 female patients who underwent thyroidectomy for thyroid carcinoma. All patients had multiple and separate papillary carcinomas (range, two to six). Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-capture microdissection. Loss of heterozygosity assays for three microsatellite polymorphic markers for putative tumor suppressor genes on chromosomes 3p25 (D3S1597), 9p21 (D9S161), and 18p11.22-p11 (D18S53) were done. In addition, X-chromosome inactivation analysis was done on the tumors from all patients.
RESULTS: Twenty of 22 (91%) cases showed allelic loss in one or more of the papillary lesions in at least one of the three polymorphic markers analyzed. Concordant allelic loss patterns between coexisting papillary tumors were seen in 20 of 23 (87%) cases. A concordant pattern of nonrandom X-chromosome inactivation in the multiple coexisting papillary lesions was seen in all informative cases.
CONCLUSION: Our data suggest that the multifocal tumors in patients with papillary thyroid carcinoma often arise from the same clone. Thus, intrathryoid metastasis may play an important role in the spread of papillary thyroid carcinoma, a finding that has important therapeutic, diagnostic, and prognostic implications.

Entities:  

Mesh:

Year:  2006        PMID: 16638846     DOI: 10.1158/1078-0432.CCR-05-2818

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  26 in total

1.  Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization.

Authors:  Xingyun Su; Shitu Chen; Kuifeng He; Zhuochao Mao; Jiaying Ruan; Jie Zhou; Xiaodong Teng; Judy Jin; Thomas J Fahey; Weibin Wang; Lisong Teng
Journal:  Endocrine       Date:  2019-02-26       Impact factor: 3.633

2.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

Review 3.  Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature.

Authors:  Elisabetta Kuhn; Linda Teller; Simonetta Piana; Juan Rosai; Maria J Merino
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

4.  Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features.

Authors:  Young Chan Lee; Young Gyu Eun; Yu-Mee Sohn; Sang Youl Rhee; Il Ki Hong; Suk Chon; Seung Joon Oh; Deog Yoon Kim
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

5.  Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.

Authors:  Zhong-Zhi Lu; Yan Zhang; Song-Feng Wei; Dong-Sheng Li; Qing-Hua Zhu; Si-Jing Sun; Min Li; L I Li
Journal:  Mol Clin Oncol       Date:  2015-01-23

6.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.

Authors:  Benjamin D Hedley; Kedar S Vaidya; Pushar Phadke; Lisa MacKenzie; David W Dales; Carl O Postenka; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

7.  How Many Contralateral Carcinomas in Patients with Unilateral Papillary Thyroid Microcarcinoma are Preoperatively Misdiagnosed as Benign?

Authors:  Zeng Gui Wu; Xing Qiang Yan; Ru Si Su; Zhao Sheng Ma; Bo Jian Xie; Fei Lin Cao
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

8.  Cell-Size Pleomorphism Drives Aberrant Clone Dispersal in Proliferating Epithelia.

Authors:  Subramanian P Ramanathan; Matej Krajnc; Matthew C Gibson
Journal:  Dev Cell       Date:  2019-09-05       Impact factor: 12.270

Review 9.  Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Svante Jansson; Marcin Barczyński; Peter Goretzki
Journal:  Langenbecks Arch Surg       Date:  2013-11-22       Impact factor: 3.445

10.  Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.

Authors:  Sinéad T Aherne; Paul C Smyth; Richard J Flavin; Susan M Russell; Karen M Denning; Jing Huan Li; Simone M Guenther; John J O'Leary; Orla M Sheils
Journal:  Mol Cancer       Date:  2008-12-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.